Last year was somewhat of a pedestrian year for mass spectrometry (MS), with the market growing modestly in the mid-single digit range. Market growth was driven mainly by demand for LC/MS technologies, offset by weak demand for portable and in-field MS and magnetic sector MS instruments. For 2014, the overall market for MS is forecast […]
The life science instrumentation (LSI) market is the largest technology sector of the instrument market. It accounts for nearly a quarter of total analytical instruments demand and includes a broad spectrum of technologies grouped into 13 technology categories. In 2013, the LSI market increased 3.3% to $11.1 billion. Most LSI technologies are heavily reliant on […]
The separations market accounts for 17% of the total analytical and life sciences instrumentation industry and increased 1.5% to $7.6 billion in 2013. Demand was mainly driven by the aftermarket and service, while demand for initial systems increased about 1% for the year. Capital expenditures by industrial segments, such as pharmaceutical and chemical markets, were […]
Thermo and Life The pending merger (see IBO 4/15/13) will create an industry behemoth and creates new challenges for competitors, such as those in the lab distribution market. It also will provide Thermo with a commanding position as a supplier to pharmaceutical and biotechnology companies for both instruments and consumables. The integration process will be […]
Another Rough Year Last year was a challenging year for analytical instrument makers in many respects. Slower industrial markets and the US government sequestration, which curtailed demand from government and academic markets, resulted in modest sales growth for many companies. Chinese sales growth slowed overall and, although Europe stabilized, sales growth was uneven. Some companies […]
Milwaukee, WI 1/3/14—ChemWare, a provider of information management systems to lab markets, has been acquired by Dohmen, an outsourced services company for health care. In addition to ChemWare, Dohmen also announced the acquisitions of Red Arrow Labs and Clinical Path Consulting. “Our life science and healthcare clients are increasingly interested in using technology to connect […]
Washington, DC 1/14/14; San Francisco, CA 1/14/14—During its presentation at the J.P. Morgan Healthcare Conference, Illumina announced its financial guidance for 2014 and made announcements regarding its sequencing and diagnostics businesses. For 2014, the company forecast revenues to grow 15%–17% and non-GAAP diluted EPS to be $2.00–$2.06. Gross margins are expected to be 70%. The […]
Brussels, Belgium 1/9/14—Food and pharmaceutical lab services firm Eurofins has agreed to acquire Merck Millipore’s (EMD Millipore in the US and Canada) Discovery and Development Solutions business (DDS) for an undisclosed amount. DDS provides bioanalytical testing and early-state discovery services and products to the biopharmaceutical market, including discovery pharmacology services and bioanalytical testing to support […]
Chalfont St. Giles, England 1/6/13; Waltham, MA 1/6/13—GE Healthcare’s Life Sciences division has agreed to acquire Thermo Fisher Scientific’s cell culture media and sera, and gene modulation and magnetic bead businesses for $1.06 billion. The businesses’ estimated combined 2013 revenues were $250 million. The sale of the businesses was required by the EU for approval […]
The instrument industry’s performance in 2013 was even more disappointing than in 2012, as a modest rebound was anticipated. Widespread economic malaise and disruptive budgeting decisions, especially in the US, generated considerable uncertainty about future business prospects. Such uncertainty negatively impacted lab capital expenditures. The very real economic effects of budget sequestration in the US […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
